世界の非ステロイド系抗炎症薬（NSAID）市場予測（～2024年）

• 英文タイトル：Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR09D4160 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートは、非ステロイド系抗炎症薬（NSAID）の世界市場について調べ、まとめました。種類別セグメントは、アスピリン、イブプロフェン、ナプロキセン、セレコキシブ、その他等、用途別セグメントは、ドラッグストア、病院薬局、オンライン等に区分しました。非ステロイド系抗炎症薬（NSAID）の世界市場概観、企業動向、企業別非ステロイド系抗炎症薬（NSAID）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・非ステロイド系抗炎症薬（NSAID）の市場概観 ・非ステロイド系抗炎症薬（NSAID）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・非ステロイド系抗炎症薬（NSAID）の企業別販売動向、市場シェア、市場集中度、競争動向 ・非ステロイド系抗炎症薬（NSAID）の世界市場規模 ・非ステロイド系抗炎症薬（NSAID）の北米市場分析（アメリカ、カナダ、メキシコ等） ・非ステロイド系抗炎症薬（NSAID）のアメリカ市場規模推移 ・非ステロイド系抗炎症薬（NSAID）のカナダ市場規模推移 ・非ステロイド系抗炎症薬（NSAID）のメキシコ市場規模推移 ・非ステロイド系抗炎症薬（NSAID）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・非ステロイド系抗炎症薬（NSAID）のドイツ市場規模推移 ・非ステロイド系抗炎症薬（NSAID）のイギリス市場規模推移 ・非ステロイド系抗炎症薬（NSAID）のロシア市場規模推移 ・非ステロイド系抗炎症薬（NSAID）のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・非ステロイド系抗炎症薬（NSAID）の日本市場規模推移 ・非ステロイド系抗炎症薬（NSAID）の中国市場規模推移 ・非ステロイド系抗炎症薬（NSAID）の韓国市場規模推移 ・非ステロイド系抗炎症薬（NSAID）のインド市場規模推移 ・非ステロイド系抗炎症薬（NSAID）の東南アジア市場規模推移 ・非ステロイド系抗炎症薬（NSAID）の南米市場分析（ブラジル、アルゼンチン等） ・非ステロイド系抗炎症薬（NSAID）の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・非ステロイド系抗炎症薬（NSAID）の種類別分析/販売量、売上、市場シェア（アスピリン、イブプロフェン、ナプロキセン、セレコキシブ、その他） ・非ステロイド系抗炎症薬（NSAID）の用途別分析/市場規模（ドラッグストア、病院薬局、オンライン） ・非ステロイド系抗炎症薬（NSAID）の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・非ステロイド系抗炎症薬（NSAID）の販売チャネル・代理店・貿易業者・ディーラー分析

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.

Scope of the Report:
The global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market by product type and applications/end industries.

Market Segment by Companies, this report covers
Roche (including Genentech)
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson & Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical Co

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Aspirin
Ibuprofen
Naproxen
Celecoxib
Others

Market Segment by Applications, can be divided into
Drug Store
Hospital Pharmacies
Online

レポート目次

---

Table of Contents

1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Overview
1.1 Product Overview and Scope of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
1.2 Classification of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Types
1.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Comparison by Types (2019-2024)
1.2.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Types in 2018
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Celecoxib
1.2.7 Others
1.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market by Application
1.3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.3.4 Online
1.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market by Regions
1.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2014-2024)
1.5 Global Market Size of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (2014-2024)
2 Manufacturers Profiles
2.1 Roche (including Genentech)
2.1.1 Business Overview
2.1.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche (including Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
2.3 B-MS
2.3.1 Business Overview
2.3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
2.4 Merck
2.4.1 Business Overview
2.4.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
2.7 Eli Lilly and Company
2.7.1 Business Overview
2.7.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
2.8 Johnson & Johnson
2.8.1 Business Overview
2.8.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
2.9 GSK
2.9.1 Business Overview
2.9.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
2.11 Boehringer Ingelheim
2.11.1 Business Overview
2.11.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
2.12 Zhejiang Jiuzhou Pharmaceutical Co
2.12.1 Business Overview
2.12.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Zhejiang Jiuzhou Pharmaceutical Co Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Competition, by Players
3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share
3.2.2 Top 10 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share
3.3 Market Competition Trend
4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions
4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Regions
4.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
4.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
4.5 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
5 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries
5.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2014-2019)
5.2 USA Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
5.3 Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
5.4 Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
6 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries
6.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2014-2019)
6.2 Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
6.3 UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
6.4 France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
6.5 Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
6.6 Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries
7.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2014-2019)
7.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
7.3 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
7.4 Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
7.5 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
8 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries
8.1 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2014-2019)
8.2 Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
8.3 Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
8.4 Colombia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries
9.1 Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2014-2019)
9.2 Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
9.3 UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
9.4 Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
9.5 Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
9.6 South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
10 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment by Type
10.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type (2014-2019)
10.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Type (2019-2024)
10.3 Aspirin Revenue Growth Rate (2014-2024)
10.4 Ibuprofen Revenue Growth Rate (2014-2024)
10.5 Naproxen Revenue Growth Rate (2014-2024)
10.6 Celecoxib Revenue Growth Rate (2014-2024)
10.7 Others Revenue Growth Rate (2014-2024)
11 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment by Application
11.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2014-2019)
11.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Application (2019-2024)
11.3 Drug Store Revenue Growth (2014-2019)
11.4 Hospital Pharmacies Revenue Growth (2014-2019)
11.5 Online Revenue Growth (2014-2019)
12 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast (2019-2024)
12.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast (2019-2024)
12.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Regions (2019-2024)
12.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)
12.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)
12.6 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Picture
Table Product Specifications of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Revenue (Million USD) Market Split by Product Type
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Types in 2018
Figure Aspirin Picture
Figure Ibuprofen Picture
Figure Naproxen Picture
Figure Celecoxib Picture
Figure Others Picture
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Application (2014-2024)
Figure Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Applications in 2018
Figure Drug Store Picture
Figure Hospital Pharmacies Picture
Figure Online Picture
Table Global Market Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2014-2024)
Table Roche (including Genentech) Basic Information, Manufacturing Base and Competitors
Table Roche (including Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
Table Roche (including Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
Table Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
Table B-MS Basic Information, Manufacturing Base and Competitors
Table B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
Table B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
Table Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
Table Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
Table Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
Table Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
Table Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
Table GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
Table Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
Table Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
Table Zhejiang Jiuzhou Pharmaceutical Co Basic Information, Manufacturing Base and Competitors
Table Zhejiang Jiuzhou Pharmaceutical Co Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
Table Zhejiang Jiuzhou Pharmaceutical Co Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Players (2014-2019)
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players (2014-2019)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players in 2017
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players in 2018
Figure Global Top 5 Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in 2018
Figure Global Top 10 Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in 2018
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Regions (2014-2019)
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Regions (2014-2019)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Regions (2014-2019)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Regions in 2018
Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Table North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2014-2019)
Table North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2014-2019)
Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2014-2019)
Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries in 2018
Figure USA Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Table Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2014-2019)
Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2014-2019)
Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries in 2018
Figure Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries in 2018
Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Table South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2014-2019)
Table South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2014-2019)
Figure South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2014-2019)
Figure South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries in 2018
Figure Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Colombia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries in 2018
Figure Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Figure South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Type (2014-2019)
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type (2014-2019)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type (2014-2019)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type in 2019
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Type (2019-2024)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Type (2019-2024)
Figure Global Aspirin Revenue Growth Rate (2014-2019)
Figure Global Ibuprofen Revenue Growth Rate (2014-2019)
Figure Global Naproxen Revenue Growth Rate (2014-2019)
Figure Global Celecoxib Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2014-2019)
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2014-2019)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2014-2019)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application in 2019
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Application (2019-2024)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Application (2019-2024)
Figure Global Drug Store Revenue Growth Rate (2014-2019)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Revenue Growth Rate (2014-2019)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)
Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)
Figure South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)

---